Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review.

Prata DP, Costa-Neves B, Cosme G, Vassos E.

J Psychiatr Res. 2019 Jul;114:178-207. doi: 10.1016/j.jpsychires.2019.04.007. Epub 2019 Apr 12. Review.

PMID:
31096178
2.

Transforming Summary Statistics from Logistic Regression to the Liability Scale: Application to Genetic and Environmental Risk Scores.

Gillett AC, Vassos E, Lewis CM.

Hum Hered. 2018;83(4):210-224. doi: 10.1159/000495697. Epub 2019 Mar 13.

PMID:
30865946
3.

Correction: Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia.

Sønderby IE, Gústafsson Ó, Doan NT, Hibar DP, Martin-Brevet S, Abdellaoui A, Ames D, Amunts K, Andersson M, Armstrong NJ, Bernard M, Blackburn N, Blangero J, Boomsma DI, Bralten J, Brattbak HR, Brodaty H, Brouwer RM, Bülow R, Calhoun V, Caspers S, Cavalleri G, Chen CH, Cichon S, Ciufolini S, Corvin A, Crespo-Facorro B, Curran JE, Dale AM, Dalvie S, Dazzan P, de Geus EJC, de Zubicaray GI, de Zwarte SMC, Delanty N, den Braber A, Desrivières S, Donohoe G, Draganski B, Ehrlich S, Espeseth T, Fisher SE, Franke B, Frouin V, Fukunaga M, Gareau T, Glahn DC, Grabe H, Groenewold NA, Haavik J, Håberg A, Hashimoto R, Hehir-Kwa JY, Heinz A, Hillegers MHJ, Hoffmann P, Holleran L, Hottenga JJ, Hulshoff HE, Ikeda M, Jahanshad N, Jernigan T, Jockwitz C, Johansson S, Jonsdottir GA, Jönsson EG, Kahn R, Kaufmann T, Kelly S, Kikuchi M, Knowles EEM, Kolskår KK, Kwok JB, Hellard SL, Leu C, Liu J, Lundervold AJ, Lundervold A, Martin NG, Mather K, Mathias SR, McCormack M, McMahon KL, McRae A, Milaneschi Y, Moreau C, Morris D, Mothersill D, Mühleisen TW, Murray R, Nordvik JE, Nyberg L, Olde Loohuis LM, Ophoff R, Paus T, Pausova Z, Penninx B, Peralta JM, Pike B, Prieto C, Pudas S, Quinlan E, Quintana DS, Reinbold CS, Marques TR, Reymond A, Richard G, Rodriguez-Herreros B, Roiz-Santiañez R, Rokicki J, Rucker J, Sachdev P, Sanders AM, Sando SB, Schmaal L, Schofield PR, Schork AJ, Schumann G, Shin J, Shumskaya E, Sisodiya S, Steen VM, Stein DJ, Steinberg S, Strike L, Teumer A, Thalamuthu A, Tordesillas-Gutierrez D, Turner J, Ueland T, Uhlmann A, Ulfarsson MO, van 't Ent D, van der Meer D, van Haren NEM, Vaskinn A, Vassos E, Walters GB, Wang Y, Wen W, Whelan CD, Wittfeld K, Wright M, Yamamori H, Zayats T, Agartz I, Westlye LT, Jacquemont S, Djurovic S, Stefánsson H, Stefánsson K, Thompson P, Andreassen OA; 16p11.2 European Consortium, for the ENIGMA-CNV working group.

Mol Psychiatry. 2019 Jan 31. doi: 10.1038/s41380-019-0358-8. [Epub ahead of print]

PMID:
30705424
4.

Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia.

Sønderby IE, Gústafsson Ó, Doan NT, Hibar DP, Martin-Brevet S, Abdellaoui A, Ames D, Amunts K, Andersson M, Armstrong NJ, Bernard M, Blackburn N, Blangero J, Boomsma DI, Bralten J, Brattbak HR, Brodaty H, Brouwer RM, Bülow R, Calhoun V, Caspers S, Cavalleri G, Chen CH, Cichon S, Ciufolini S, Corvin A, Crespo-Facorro B, Curran JE, Dale AM, Dalvie S, Dazzan P, de Geus EJC, de Zubicaray GI, de Zwarte SMC, Delanty N, den Braber A, Desrivières S, Donohoe G, Draganski B, Ehrlich S, Espeseth T, Fisher SE, Franke B, Frouin V, Fukunaga M, Gareau T, Glahn DC, Grabe H, Groenewold NA, Haavik J, Håberg A, Hashimoto R, Hehir-Kwa JY, Heinz A, Hillegers MHJ, Hoffmann P, Holleran L, Hottenga JJ, Hulshoff HE, Ikeda M, Jahanshad N, Jernigan T, Jockwitz C, Johansson S, Jonsdottir GA, Jönsson EG, Kahn R, Kaufmann T, Kelly S, Kikuchi M, Knowles EEM, Kolskår KK, Kwok JB, Hellard SL, Leu C, Liu J, Lundervold AJ, Lundervold A, Martin NG, Mather K, Mathias SR, McCormack M, McMahon KL, McRae A, Milaneschi Y, Moreau C, Morris D, Mothersill D, Mühleisen TW, Murray R, Nordvik JE, Nyberg L, Olde Loohuis LM, Ophoff R, Paus T, Pausova Z, Penninx B, Peralta JM, Pike B, Prieto C, Pudas S, Quinlan E, Quintana DS, Reinbold CS, Marques TR, Reymond A, Richard G, Rodriguez-Herreros B, Roiz-Santiañez R, Rokicki J, Rucker J, Sachdev P, Sanders AM, Sando SB, Schmaal L, Schofield PR, Schork AJ, Schumann G, Shin J, Shumskaya E, Sisodiya S, Steen VM, Stein DJ, Steinberg S, Strike L, Teumer A, Thalamuthu A, Tordesillas-Gutierrez D, Turner J, Ueland T, Uhlmann A, Ulfarsson MO, van 't Ent D, van der Meer D, van Haren NEM, Vaskinn A, Vassos E, Walters GB, Wang Y, Wen W, Whelan CD, Wittfeld K, Wright M, Yamamori H, Zayats T, Agartz I, Westlye LT, Jacquemont S, Djurovic S, Stefánsson H, Stefánsson K, Thompson P, Andreassen OA; 16p11.2 European Consortium, for the ENIGMA-CNV working group.

Mol Psychiatry. 2018 Oct 3. doi: 10.1038/s41380-018-0118-1. [Epub ahead of print] Erratum in: Mol Psychiatry. 2019 Jan 31;:.

PMID:
30283035
5.

Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study.

Quattrone D, Di Forti M, Gayer-Anderson C, Ferraro L, Jongsma HE, Tripoli G, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Lasalvia A, Tortelli A, Llorca PM, de Haan L, Velthorst E, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, Del-Ben CM, Menezes PR, Selten JP; EU-GEI WP2 Group, Jones PB, Kirkbride JB, Richards AL, O'Donovan MC, Sham PC, Vassos E, Rutten BP, van Os J, Morgan C, Lewis CM, Murray RM, Reininghaus U.

Psychol Med. 2019 Jun;49(8):1378-1391. doi: 10.1017/S0033291718002131. Epub 2018 Oct 4.

6.

A locus on barley chromosome 5H affects adult plant resistance to powdery mildew.

Gupta S, Vassos E, Sznajder B, Fox R, Khoo KHP, Loughman R, Chalmers KJ, Mather DE.

Mol Breed. 2018;38(8):103. doi: 10.1007/s11032-018-0858-2. Epub 2018 Jul 28.

7.

Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders.

Calafato MS, Thygesen JH, Ranlund S, Zartaloudi E, Cahn W, Crespo-Facorro B, Díez-Revuelta Á, Di Forti M; Genetic Risk and Outcome of Psychosis (GROUP) consortium, Hall MH, Iyegbe C, Jablensky A, Kahn R, Kalaydjieva L, Kravariti E, Lin K, McDonald C, McIntosh AM, McQuillin A, Picchioni M, Rujescu D, Shaikh M, Toulopoulou T, Os JV, Vassos E, Walshe M, Powell J, Lewis CM, Murray RM, Bramon E.

Br J Psychiatry. 2018 Sep;213(3):535-541. doi: 10.1192/bjp.2018.89.

8.

Prospects for using risk scores in polygenic medicine.

Lewis CM, Vassos E.

Genome Med. 2017 Nov 13;9(1):96. doi: 10.1186/s13073-017-0489-y.

9.

The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project.

Blokland GAM, Del Re EC, Mesholam-Gately RI, Jovicich J, Trampush JW, Keshavan MS, DeLisi LE, Walters JTR, Turner JA, Malhotra AK, Lencz T, Shenton ME, Voineskos AN, Rujescu D, Giegling I, Kahn RS, Roffman JL, Holt DJ, Ehrlich S, Kikinis Z, Dazzan P, Murray RM, Di Forti M, Lee J, Sim K, Lam M, Wolthusen RPF, de Zwarte SMC, Walton E, Cosgrove D, Kelly S, Maleki N, Osiecki L, Picchioni MM, Bramon E, Russo M, David AS, Mondelli V, Reinders AATS, Falcone MA, Hartmann AM, Konte B, Morris DW, Gill M, Corvin AP, Cahn W, Ho NF, Liu JJ, Keefe RSE, Gollub RL, Manoach DS, Calhoun VD, Schulz SC, Sponheim SR, Goff DC, Buka SL, Cherkerzian S, Thermenos HW, Kubicki M, Nestor PG, Dickie EW, Vassos E, Ciufolini S, Reis Marques T, Crossley NA, Purcell SM, Smoller JW, van Haren NEM, Toulopoulou T, Donohoe G, Goldstein JM, Seidman LJ, McCarley RW, Petryshen TL.

Schizophr Res. 2018 May;195:306-317. doi: 10.1016/j.schres.2017.09.024. Epub 2017 Oct 3.

10.

Loci on chromosomes 1A and 2A affect resistance to tan (yellow) spot in wheat populations not segregating for tsn1.

Shankar M, Jorgensen D, Taylor J, Chalmers KJ, Fox R, Hollaway GJ, Neate SM, McLean MS, Vassos E, Golzar H, Loughman R, Mather DE.

Theor Appl Genet. 2017 Dec;130(12):2637-2654. doi: 10.1007/s00122-017-2981-6. Epub 2017 Sep 14.

11.

A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains.

Ranlund S, Calafato S, Thygesen JH, Lin K, Cahn W, Crespo-Facorro B, de Zwarte SMC, Díez Á, Di Forti M; GROUP, Iyegbe C, Jablensky A, Jones R, Hall MH, Kahn R, Kalaydjieva L, Kravariti E, McDonald C, McIntosh AM, McQuillin A; PEIC, Picchioni M, Prata DP, Rujescu D, Schulze K, Shaikh M, Toulopoulou T, van Haren N, van Os J, Vassos E, Walshe M; WTCCC2, Lewis C, Murray RM, Powell J, Bramon E.

Am J Med Genet B Neuropsychiatr Genet. 2018 Jan;177(1):21-34. doi: 10.1002/ajmg.b.32581. Epub 2017 Aug 29.

12.

Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study.

Ajnakina O, Lally J, Di Forti M, Kolliakou A, Gardner-Sood P, Lopez-Morinigo J, Dazzan P, Pariante CM, Mondelli V, MacCabe J, David AS, Gaughran F, Murray RM, Vassos E.

Soc Psychiatry Psychiatr Epidemiol. 2017 Sep;52(9):1101-1111. doi: 10.1007/s00127-017-1417-6. Epub 2017 Jul 5.

13.

Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis.

Moukhtarian TR, Cooper RE, Vassos E, Moran P, Asherson P.

Eur Psychiatry. 2017 Jul;44:198-207. doi: 10.1016/j.eurpsy.2017.05.021. Epub 2017 May 25. Review.

PMID:
28646732
14.

An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis.

Vassos E, Di Forti M, Coleman J, Iyegbe C, Prata D, Euesden J, O'Reilly P, Curtis C, Kolliakou A, Patel H, Newhouse S, Traylor M, Ajnakina O, Mondelli V, Marques TR, Gardner-Sood P, Aitchison KJ, Powell J, Atakan Z, Greenwood KE, Smith S, Ismail K, Pariante C, Gaughran F, Dazzan P, Markus HS, David AS, Lewis CM, Murray RM, Breen G.

Biol Psychiatry. 2017 Mar 15;81(6):470-477. doi: 10.1016/j.biopsych.2016.06.028. Epub 2016 Aug 6.

15.

Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot Study.

Trotta A, Iyegbe C, Di Forti M, Sham PC, Campbell DD, Cherny SS, Mondelli V, Aitchison KJ, Murray RM, Vassos E, Fisher HL.

PLoS One. 2016 Sep 20;11(9):e0163319. doi: 10.1371/journal.pone.0163319. eCollection 2016.

16.

Microduplications at the pseudoautosomal SHOX locus in autism spectrum disorders and related neurodevelopmental conditions.

Tropeano M, Howley D, Gazzellone MJ, Wilson CE, Ahn JW, Stavropoulos DJ, Murphy CM, Eis PS, Hatchwell E, Dobson RJ, Robertson D, Holder M, Irving M, Josifova D, Nehammer A, Ryten M, Spain D, Pitts M, Bramham J, Asherson P, Curran S, Vassos E, Breen G, Flinter F, Ogilvie CM, Collier DA, Scherer SW, McAlonan GM, Murphy DG.

J Med Genet. 2016 Aug;53(8):536-47. doi: 10.1136/jmedgenet-2015-103621. Epub 2016 Apr 12.

PMID:
27073233
17.

Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis.

Marconi A, Di Forti M, Lewis CM, Murray RM, Vassos E.

Schizophr Bull. 2016 Sep;42(5):1262-9. doi: 10.1093/schbul/sbw003. Epub 2016 Feb 15. Review.

18.

Urban-rural differences in incidence rates of psychiatric disorders in Denmark.

Vassos E, Agerbo E, Mors O, Pedersen CB.

Br J Psychiatry. 2016 May;208(5):435-40. doi: 10.1192/bjp.bp.114.161091. Epub 2015 Dec 17.

PMID:
26678865
19.

The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: A systematic review and meta-analysis.

Cooper RE, Tye C, Kuntsi J, Vassos E, Asherson P.

J Affect Disord. 2016 Jan 15;190:474-482. doi: 10.1016/j.jad.2015.09.053. Epub 2015 Oct 29. Review.

PMID:
26551407
20.

Impact of childhood adversities on specific symptom dimensions in first-episode psychosis.

Ajnakina O, Trotta A, Oakley-Hannibal E, Di Forti M, Stilo SA, Kolliakou A, Gardner-Sood P, Gaughran F, David AS, Dazzan P, Pariante C, Mondelli V, Morgan C, Vassos E, Murray RM, Fisher HL.

Psychol Med. 2016 Jan;46(2):317-26. doi: 10.1017/S0033291715001816. Epub 2015 Sep 18.

PMID:
26383785
21.

Cannabis and psychosis - Authors' reply.

Di Forti M, Vassos E, Lynskey M, Craig M, Murray RM.

Lancet Psychiatry. 2015 May;2(5):382. doi: 10.1016/S2215-0366(15)00177-7. Epub 2015 Apr 28. No abstract available.

PMID:
26360275
22.

Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis.

Cooper RE, Tye C, Kuntsi J, Vassos E, Asherson P.

J Psychopharmacol. 2015 Jul;29(7):753-63. doi: 10.1177/0269881115587958. Epub 2015 Jun 3. Review.

PMID:
26040902
23.

Schizophrenia patients with high intelligence: A clinically distinct sub-type of schizophrenia?

Černis E, Vassos E, Brébion G, McKenna PJ, Murray RM, David AS, MacCabe JH.

Eur Psychiatry. 2015 Jul;30(5):628-32. doi: 10.1016/j.eurpsy.2015.02.007. Epub 2015 Mar 6.

PMID:
25752725
24.

Clinical utility gene card for: 15q13.3 microdeletion syndrome.

Tropeano M, Andrieux J, Vassos E, Collier DA.

Eur J Hum Genet. 2014 Nov;22(11). doi: 10.1038/ejhg.2014.88. Epub 2014 May 14. No abstract available.

25.

Random or stochastic monoallelic expressed genes are enriched for neurodevelopmental disorder candidate genes.

Jeffries AR, Collier DA, Vassos E, Curran S, Ogilvie CM, Price J.

PLoS One. 2013 Dec 27;8(12):e85093. doi: 10.1371/journal.pone.0085093. eCollection 2013.

26.

Ohnologs are overrepresented in pathogenic copy number mutations.

McLysaght A, Makino T, Grayton HM, Tropeano M, Mitchell KJ, Vassos E, Collier DA.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):361-6. doi: 10.1073/pnas.1309324111. Epub 2013 Dec 24.

27.

Independent modulation of engagement and connectivity of the facial network during affect processing by CACNA1C and ANK3 risk genes for bipolar disorder.

Dima D, Jogia J, Collier D, Vassos E, Burdick KE, Frangou S.

JAMA Psychiatry. 2013 Dec;70(12):1303-11. doi: 10.1001/jamapsychiatry.2013.2099.

PMID:
24108394
28.

Male-biased autosomal effect of 16p13.11 copy number variation in neurodevelopmental disorders.

Tropeano M, Ahn JW, Dobson RJ, Breen G, Rucker J, Dixit A, Pal DK, McGuffin P, Farmer A, White PS, Andrieux J, Vassos E, Ogilvie CM, Curran S, Collier DA.

PLoS One. 2013 Apr 18;8(4):e61365. doi: 10.1371/journal.pone.0061365. Print 2013.

29.

Systematic meta-analyses and field synopsis of genetic association studies of violence and aggression.

Vassos E, Collier DA, Fazel S.

Mol Psychiatry. 2014 Apr;19(4):471-7. doi: 10.1038/mp.2013.31. Epub 2013 Apr 2. Review.

30.

Common variant at 16p11.2 conferring risk of psychosis.

Steinberg S, de Jong S, Mattheisen M, Costas J, Demontis D, Jamain S, Pietiläinen OP, Lin K, Papiol S, Huttenlocher J, Sigurdsson E, Vassos E, Giegling I, Breuer R, Fraser G, Walker N, Melle I, Djurovic S, Agartz I, Tuulio-Henriksson A, Suvisaari J, Lönnqvist J, Paunio T, Olsen L, Hansen T, Ingason A, Pirinen M, Strengman E; GROUP, Hougaard DM, Orntoft T, Didriksen M, Hollegaard MV, Nordentoft M, Abramova L, Kaleda V, Arrojo M, Sanjuán J, Arango C, Etain B, Bellivier F, Méary A, Schürhoff F, Szoke A, Ribolsi M, Magni V, Siracusano A, Sperling S, Rossner M, Christiansen C, Kiemeney LA, Franke B, van den Berg LH, Veldink J, Curran S, Bolton P, Poot M, Staal W, Rehnstrom K, Kilpinen H, Freitag CM, Meyer J, Magnusson P, Saemundsen E, Martsenkovsky I, Bikshaieva I, Martsenkovska I, Vashchenko O, Raleva M, Paketchieva K, Stefanovski B, Durmishi N, Pejovic Milovancevic M, Lecic Tosevski D, Silagadze T, Naneishvili N, Mikeladze N, Surguladze S, Vincent JB, Farmer A, Mitchell PB, Wright A, Schofield PR, Fullerton JM, Montgomery GW, Martin NG, Rubino IA, van Winkel R, Kenis G, De Hert M, Réthelyi JM, Bitter I, Terenius L, Jönsson EG, Bakker S, van Os J, Jablensky A, Leboyer M, Bramon E, Powell J, Murray R, Corvin A, Gill M, Morris D, O'Neill FA, Kendler K, Riley B; Wellcome Trust Case Control Consortium 2, Craddock N, Owen MJ, O'Donovan MC, Thorsteinsdottir U, Kong A, Ehrenreich H, Carracedo A, Golimbet V, Andreassen OA, Børglum AD, Mors O, Mortensen PB, Werge T, Ophoff RA, Nöthen MM, Rietschel M, Cichon S, Ruggeri M, Tosato S, Palotie A, St Clair D, Rujescu D, Collier DA, Stefansson H, Stefansson K.

Mol Psychiatry. 2014 Jan;19(1):108-14. doi: 10.1038/mp.2012.157. Epub 2012 Nov 20.

31.

Meta-analysis of the association of urbanicity with schizophrenia.

Vassos E, Pedersen CB, Murray RM, Collier DA, Lewis CM.

Schizophr Bull. 2012 Nov;38(6):1118-23. doi: 10.1093/schbul/sbs096. Epub 2012 Sep 26. Review.

32.

Genome-wide significant association between a 'negative mood delusions' dimension in bipolar disorder and genetic variation on chromosome 3q26.1.

Meier S, Mattheisen M, Vassos E, Strohmaier J, Treutlein J, Josef F, Breuer R, Degenhardt F, Mühleisen TW, Müller-Myhsok B, Steffens M, Schmael C, McMahon FJ; Bipolar Disorder Genome Study (BiGS) Consortium, Nöthen MM, Cichon S, Schulze TG, Rietschel M, Kelsoe JR, Greenwood TA, Nievergelt CM, Barrett TB, McKinney R, Shilling PD, Schork NJ, Smith EN, Bloss CS, Nurnberger J, Edenberg HJ, Foroud T, Koller DL, Gershon ES, Liu CY, Badner JA, Scheftner W, Lawson WB, Nwulia EA, Hipolito M, Coryell W, Rice J, Byerley W, McMahon F, Chen DT, Schulze TG, Berrettini W, Potash JB, Zandi PP, Mahon PB, McInnis M, Craig D, Szelinger S.

Transl Psychiatry. 2012 Sep 25;2:e165. doi: 10.1038/tp.2012.81.

33.

Linear and non-linear associations of symptom dimensions and cognitive function in first-onset psychosis.

Kravariti E, Russo M, Vassos E, Morgan K, Fearon P, Zanelli JW, Demjaha A, Lappin JM, Tsakanikos E, Dazzan P, Morgan C, Doody GA, Harrison G, Jones PB, Murray RM, Reichenberg A.

Schizophr Res. 2012 Sep;140(1-3):221-31. doi: 10.1016/j.schres.2012.06.008. Epub 2012 Jul 4.

PMID:
22766128
34.

Replication study and meta-analysis in European samples supports association of the 3p21.1 locus with bipolar disorder.

Vassos E, Steinberg S, Cichon S, Breen G, Sigurdsson E, Andreassen OA, Djurovic S, Morken G, Grigoroiu-Serbanescu M, Diaconu CC, Czerski PM, Hauser J, Babadjanova G, Abramova LI, Mühleisen TW, Nöthen MM, Rietschel M, McGuffin P, St Clair D, Gustafsson O, Melle I, Pietiläinen OP, Ruggeri M, Tosato S, Werge T, Ophoff RA; GROUP Consortium, Rujescu D, Børglum AD, Mors O, Mortensen PB, Demontis D, Hollegaard MV, van Winkel R, Kenis G, De Hert M, Réthelyi JM, Bitter I, Rubino IA, Golimbet V, Kiemeney LA, van den Berg LH, Franke B, Jönsson EG, Farmer A, Stefansson H, Stefansson K, Collier DA.

Biol Psychiatry. 2012 Oct 15;72(8):645-50. doi: 10.1016/j.biopsych.2012.02.040. Epub 2012 May 5.

PMID:
22560537
35.

Association analysis of STX1A gene variants in common forms of migraine.

Tropeano M, Wöber-Bingöl C, Karwautz A, Wagner G, Vassos E, Campos-de-Sousa S, Graggaber A, Zesch HE, Kienbacher C, Natriashvili S, Kanbur I, Wöber C, Collier DA.

Cephalalgia. 2012 Feb;32(3):203-12. doi: 10.1177/0333102411433300. Epub 2012 Jan 16.

PMID:
22250207
36.

The Association between COMT, BDNF, and NRG1 and Premorbid Social Functioning in Patients with Psychosis, Their Relatives, and Controls.

Walshe M, Vassos E, Picchioni M, Shaikh M, Toulopoulou T, Collier D, McDonald C, Murray R, Bramon E.

Scientifica (Cairo). 2012;2012:560514. doi: 10.6064/2012/560514. Epub 2012 May 21.

37.

Common variants at VRK2 and TCF4 conferring risk of schizophrenia.

Steinberg S, de Jong S; Irish Schizophrenia Genomics Consortium, Andreassen OA, Werge T, Børglum AD, Mors O, Mortensen PB, Gustafsson O, Costas J, Pietiläinen OP, Demontis D, Papiol S, Huttenlocher J, Mattheisen M, Breuer R, Vassos E, Giegling I, Fraser G, Walker N, Tuulio-Henriksson A, Suvisaari J, Lönnqvist J, Paunio T, Agartz I, Melle I, Djurovic S, Strengman E; GROUP, Jürgens G, Glenthøj B, Terenius L, Hougaard DM, Ørntoft T, Wiuf C, Didriksen M, Hollegaard MV, Nordentoft M, van Winkel R, Kenis G, Abramova L, Kaleda V, Arrojo M, Sanjuán J, Arango C, Sperling S, Rossner M, Ribolsi M, Magni V, Siracusano A, Christiansen C, Kiemeney LA, Veldink J, van den Berg L, Ingason A, Muglia P, Murray R, Nöthen MM, Sigurdsson E, Petursson H, Thorsteinsdottir U, Kong A, Rubino IA, De Hert M, Réthelyi JM, Bitter I, Jönsson EG, Golimbet V, Carracedo A, Ehrenreich H, Craddock N, Owen MJ, O'Donovan MC; Wellcome Trust Case Control Consortium 2, Ruggeri M, Tosato S, Peltonen L, Ophoff RA, Collier DA, St Clair D, Rietschel M, Cichon S, Stefansson H, Rujescu D, Stefansson K.

Hum Mol Genet. 2011 Oct 15;20(20):4076-81. doi: 10.1093/hmg/ddr325. Epub 2011 Jul 26.

38.

No association between a common single nucleotide polymorphism, rs4141463, in the MACROD2 gene and autism spectrum disorder.

Curran S, Bolton P, Rozsnyai K, Chiocchetti A, Klauck SM, Duketis E, Poustka F, Schlitt S, Freitag CM, Lee I, Muglia P; ITAN, Poot M, Staal W, de Jonge MV, Ophoff RA, Lewis C, Skuse D, Mandy W, Vassos E, Fossdal R, Magnusson P, Hreidarsson S, Saemundsen E, Stefansson H, Stefansson K, Collier D.

Am J Med Genet B Neuropsychiatr Genet. 2011 Sep;156B(6):633-9. doi: 10.1002/ajmg.b.31201. Epub 2011 Jun 8.

PMID:
21656903
39.

The impact of the CACNA1C gene polymorphism on frontolimbic function in bipolar disorder.

Jogia J, Ruberto G, Lelli-Chiesa G, Vassos E, Maierú M, Tatarelli R, Girardi P, Collier D, Frangou S.

Mol Psychiatry. 2011 Nov;16(11):1070-1. doi: 10.1038/mp.2011.49. Epub 2011 Apr 26. No abstract available.

PMID:
21519340
40.

The cognitive impact of the ANK3 risk variant for bipolar disorder: initial evidence of selectivity to signal detection during sustained attention.

Ruberto G, Vassos E, Lewis CM, Tatarelli R, Girardi P, Collier D, Frangou S.

PLoS One. 2011 Jan 31;6(1):e16671. doi: 10.1371/journal.pone.0016671.

41.

Initial evidence for the role of CACNA1C on subcortical brain morphology in patients with bipolar disorder.

Perrier E, Pompei F, Ruberto G, Vassos E, Collier D, Frangou S.

Eur Psychiatry. 2011 Apr;26(3):135-7. doi: 10.1016/j.eurpsy.2010.10.004. Epub 2011 Feb 2.

PMID:
21292451
42.

Replication of association of 3p21.1 with susceptibility to bipolar disorder but not major depression.

Breen G, Lewis CM, Vassos E, Pergadia ML, Blackwood DH, Boomsma DI, Penninx B, Sullivan PF, Pedroso I, Collier D, McGuffin P.

Nat Genet. 2011 Jan;43(1):3-5; author reply 5. doi: 10.1038/ng0111-3. No abstract available.

PMID:
21217634
43.

Huntington's disease in Greece: the experience of 14 years.

Panas M, Karadima G, Vassos E, Kalfakis N, Kladi A, Christodoulou K, Vassilopoulos D.

Clin Genet. 2011 Dec;80(6):586-90. doi: 10.1111/j.1399-0004.2010.01603.x. Epub 2010 Dec 20.

PMID:
21166788
44.

Penetrance for copy number variants associated with schizophrenia.

Vassos E, Collier DA, Holden S, Patch C, Rujescu D, St Clair D, Lewis CM.

Hum Mol Genet. 2010 Sep 1;19(17):3477-81. doi: 10.1093/hmg/ddq259. Epub 2010 Jun 29.

PMID:
20587603
45.

Association of Neuregulin 1 rs3924999 genotype with antisaccades and smooth pursuit eye movements.

Schmechtig A, Vassos E, Kumari V, Hutton SB, Collier DA, Morris RG, Williams SC, Ettinger U.

Genes Brain Behav. 2010 Aug;9(6):621-7. doi: 10.1111/j.1601-183X.2010.00594.x. Epub 2010 May 18.

46.

Genetic overlap between episodic memory deficits and schizophrenia: results from the Maudsley Twin Study.

Owens SF, Picchioni MM, Rijsdijk FV, Stahl D, Vassos E, Rodger AK, Collier DA, Murray RM, Toulopoulou T.

Psychol Med. 2011 Mar;41(3):521-32. doi: 10.1017/S0033291710000942. Epub 2010 May 12.

PMID:
20459888
47.

Evidence of association of KIBRA genotype with episodic memory in families of psychotic patients and controls.

Vassos E, Bramon E, Picchioni M, Walshe M, Filbey FM, Kravariti E, McDonald C, Murray RM, Collier DA, Toulopoulou T.

J Psychiatr Res. 2010 Sep;44(12):795-8. doi: 10.1016/j.jpsychires.2010.01.012. Epub 2010 Feb 24.

PMID:
20185150
48.

Factor structures of the neurocognitive assessments and familial analysis in first-episode schizophrenia patients, their relatives and controls.

Wang Q, Vassos E, Deng W, Ma X, Hu X, Murray RM, Collier DA, Li T.

Aust N Z J Psychiatry. 2010 Feb;44(2):109-19. doi: 10.3109/00048670903270381.

PMID:
20113299
49.

A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia.

Ingason A, Giegling I, Cichon S, Hansen T, Rasmussen HB, Nielsen J, Jürgens G, Muglia P, Hartmann AM, Strengman E, Vasilescu C, Mühleisen TW, Djurovic S, Melle I, Lerer B, Möller HJ, Francks C, Pietiläinen OP, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Walshe M, Vassos E, Di Forti M, Murray R, Bonetto C, Tosato S; GROUP Investigators, Cantor RM, Rietschel M, Craddock N, Owen MJ, Peltonen L, Andreassen OA, Nöthen MM, St Clair D, Ophoff RA, O'Donovan MC, Collier DA, Werge T, Rujescu D.

Hum Mol Genet. 2010 Apr 1;19(7):1379-86. doi: 10.1093/hmg/ddq009. Epub 2010 Jan 12.

50.

Expanding the range of ZNF804A variants conferring risk of psychosis.

Steinberg S, Mors O, Børglum AD, Gustafsson O, Werge T, Mortensen PB, Andreassen OA, Sigurdsson E, Thorgeirsson TE, Böttcher Y, Olason P, Ophoff RA, Cichon S, Gudjonsdottir IH, Pietiläinen OP, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Athanasiu L, Suvisaari J, Lonnqvist J, Paunio T, Hartmann A, Jürgens G, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Breuer R, Möller HJ, Giegling I, Glenthøj B, Rasmussen HB, Mattheisen M, Bitter I, Réthelyi JM, Sigmundsson T, Fossdal R, Thorsteinsdottir U, Ruggeri M, Tosato S, Strengman E; Genetic Risk and Outcome in Psychosis, Kiemeney LA, Melle I, Djurovic S, Abramova L, Kaleda V, Walshe M, Bramon E, Vassos E, Li T, Fraser G, Walker N, Toulopoulou T, Yoon J, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Jönsson EG, Terenius L, Agartz I, Petursson H, Nöthen MM, Rietschel M, Peltonen L, Rujescu D, Collier DA, Stefansson H, St Clair D, Stefansson K.

Mol Psychiatry. 2011 Jan;16(1):59-66. doi: 10.1038/mp.2009.149. Epub 2010 Jan 5.

Supplemental Content

Loading ...
Support Center